Skip to main content
. 2023 Mar 27;2023(3):CD009885. doi: 10.1002/14651858.CD009885.pub3

2.7. Analysis.

2.7

Comparison 2: Independent assessor‐rated ADHD symptoms, Outcome 7: Subgroup analysis: parallel‐group trials compared with first‐period cross‐over trials